source
- Municipalities and States Grapple with Rising Health-Insurance Costs and Upcoming Medicaid Drug Pricing DeadlineMunicipalities across the country are reporting that the cost of providing health insurance to their employees is becoming increasingly unsustainable, putting pressure on local budgets. States are…
- LEO Pharma spends $435 million to acquire rare-disease skin drug dersimelagonLEO Pharma announced it will pay $435 million to buy the rights to dersimelagon, an oral MC1R agonist originally developed by Tanabe Pharma. The drug has completed Phase 3 trials for two rare phot…